Weill Cornell
Pan-Cancer Analysis Reveals Unique Features in Tumors From Younger People
Tumors in younger individuals exhibited a dysregulated molecular aging phenotype and were associated with hallmarks of premature senescence.
Fresh off its July IPO, the Swiss-American company is expanding its technological and geographical footprints with a series of collaborations and partnerships.
Breast Cancer Genetic Risk Modified by Corticosteroid Use
Some women with an elevated genetic risk of breast cancer, as gauged by a polygenic risk score, might further increase their risk if they also take corticosteroids.
Weill Cornell Medicine Launches $1.5B Program to Advance Medical Research
The funding will be used in part for a precision medicine program that will use genomics, data science, and other technologies to evaluate individual drivers of disease.
Imaging Mass Cytometry Study Reveals Immune Processes Involved in Severe COVID-19
The study's finding suggest that over-stimulation of the complement pathway along with non-specific targeting of lung tissue contribute to death from the virus.